Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study

Akio Nomura, Takeshi Masuda, Kiyofumi Shimoji, Shun Takao, Yusuke Izumi, Yusuke Araki, Yusuke Takayama, Ken Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Taku Nakashima, Hiroshi Iwamoto, Tadashi Senoo, Hiroyasu Shoda, Nobuhisa Ishikawa, Masahiro Yamasaki, Hironobu Hamada, Morihito Okada, Noboru Hattori

Open source

DOI: 10.21037/tlcr-2025-aw-1281
Published: 2026-03
Container: Translational Lung Cancer Research
Publisher: AME Publishing Company
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-2025-aw-1281,
  title = {Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study},
  author = {Akio Nomura and Takeshi Masuda and Kiyofumi Shimoji and Shun Takao and Yusuke Izumi and Yusuke Araki and Yusuke Takayama and Ken Masuda and Kakuhiro Yamaguchi and Shinjiro Sakamoto and Yasushi Horimasu and Taku Nakashima and Hiroshi Iwamoto and Tadashi Senoo and Hiroyasu Shoda and Nobuhisa Ishikawa and Masahiro Yamasaki and Hironobu Hamada and Morihito Okada and Noboru Hattori},
  year = {2026},
  journal = {Translational Lung Cancer Research},
  doi = {10.21037/tlcr-2025-aw-1281},
  url = {https://doi.org/10.21037/tlcr-2025-aw-1281}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study
AU  - Akio Nomura
AU  - Takeshi Masuda
AU  - Kiyofumi Shimoji
AU  - Shun Takao
AU  - Yusuke Izumi
AU  - Yusuke Araki
AU  - Yusuke Takayama
AU  - Ken Masuda
AU  - Kakuhiro Yamaguchi
AU  - Shinjiro Sakamoto
AU  - Yasushi Horimasu
AU  - Taku Nakashima
AU  - Hiroshi Iwamoto
AU  - Tadashi Senoo
AU  - Hiroyasu Shoda
AU  - Nobuhisa Ishikawa
AU  - Masahiro Yamasaki
AU  - Hironobu Hamada
AU  - Morihito Okada
AU  - Noboru Hattori
PY  - 2026
JO  - Translational Lung Cancer Research
DO  - 10.21037/tlcr-2025-aw-1281
UR  - https://doi.org/10.21037/tlcr-2025-aw-1281
ER  -

APA

Nomura, A., Masuda, T., Shimoji, K., Takao, S., Izumi, Y., Araki, Y., Takayama, Y., Masuda, K., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Nakashima, T., Iwamoto, H., Senoo, T., Shoda, H., Ishikawa, N., Yamasaki, M., Hamada, H., Okada, M., & Hattori, N. (2026). Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2025-aw-1281

Source records

crossref · retrieved 2026-09-26T18:24:33.741Z